Best in Biotech 16 Dec 2024
10 biotech companies to watch in 2025
As 2025 is expected to be an exciting year for the biopharma industry, discover ten biotech companies to keep an eye on in 2025.
- Latest Posts
In Depth 13 Dec 2024
Is China the future of biotech?
Delve into the ongoing transformation of China’s biotech industry in the last 10 years and in the future evolving geopolitical context.
Podcast 13 Dec 2024
Finding new treatments for peanut allergy
Individuals with peanut allergies are at constant risk of severe reactions, and this week, we talk about new treatments with Jessica Grossman of IgGenix.
News and Trends 12 Dec 2024
Top biotech deals of November 2024
November has seen a variety of biotech deals take place to advance therapies across different stages in development.
In Depth 11 Dec 2024
Targeting sugar molecules: Can glycobiology lead to a new era for cancer immunotherapy?
Find out more about the emerging field of glycobiology, which could potentially lead to a new type of cancer immunotherapy.
Antibody Therapy R&D trends and breakthrough innovations
Check out a new report exploring R&D trends and breakthrough innovations leveraging antibodies to create potentially game-changing therapies, published by our parent company Inpart.
ADVERTISEMENT
ADVERTISEMENT
More News! 10 Dec 2024
Biotech in 2024: A retrospective
2024 is coming to a close and it is time to look at how biotech performed this year. Was it a triumph or a year of cautious optimism?
How the right clinical trial design software boosts success rates
Discover key challenges in clinical trial design and learn how selecting the right software solution can significantly enhance the likelihood of trial success.
In Depth 9 Dec 2024
CAR-T cell therapy for lupus: An emerging field with great potential
Discover how the emerging field of using CAR-T cell therapy to treat lupus could offer a potential cure for the autoimmune disorder.
Podcast 6 Dec 2024
Cracking the code of biotech valuations
Our guest on the podcast this week to discuss the biotech scene in Eastern Europe, and look at some of the challenges facing biotech companies is Adam Marťák, CEO of ambiom.
In Depth 5 Dec 2024
The biggest private biotech investments in November 2024
The companies Metsera, Alentis Therapeutics, and Adcendo bagged the biggest private biotech investments in November 2024.
Best in Biotech 5 Dec 2024
Five biosimilar companies you should know about
Discover five biosimilar companies creating affordable versions of blockbuster drugs and hoping to capitalize on the upcoming patent cliff.
ADVERTISEMENT
